Literature DB >> 3279287

Calcium channel blockers in systemic hypertension.

W H Frishman1, J A Stroh, S Greenberg, T Suarez, A Karp, H Peled.   

Abstract

Alterations in transmembrane flux of calcium ions may be playing a role in the pathophysiology of systemic hypertension. Calcium channel blockers have been shown to be effective antihypertensive drugs with excellent safety profiles. They are efficacious in the long term treatment of systemic hypertension in all population subgroups, and have special applicability for treating patients with hypertensive urgencies and individuals with concomitant diseases such as angina pectoris and arrhythmias.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3279287     DOI: 10.1016/s0025-7125(16)30779-9

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  4 in total

1.  Calcium channel antagonists in the modern era of coronary thrombolysis: benefit or detriment?

Authors:  J A Foley; R C Becker
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

2.  Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension.

Authors:  P Greminger; P M Suter; D Holm; R Kobelt; W Vetter
Journal:  Clin Investig       Date:  1994-11

Review 3.  Effects of calcium channel blockers on potassium homeostasis.

Authors:  M I Freed; A Rastegar; M J Bia
Journal:  Yale J Biol Med       Date:  1991 Mar-Apr

4.  Sub-synaptic localization of Cav3.1 T-type calcium channels in the thalamus of normal and parkinsonian monkeys.

Authors:  Erdong Chen; Jean-Francois Paré; Thomas Wichmann; Yoland Smith
Journal:  Brain Struct Funct       Date:  2016-06-02       Impact factor: 3.270

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.